Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis (NCT01512277)University Hospital, Lille1998-09-01
KRN7000 in Treating Patients With Solid Tumors (NCT00003985)European Organisation for Research and Treatment of Cancer - EORTC1998-09-01
Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects (NCT02183077)Boehringer Ingelheim1998-09-01
Combination Chemotherapy in Treating Patients With Advanced Cancer (NCT00004105)NYU Langone Health1998-09-01
Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors (NCT00003768)Case Comprehensive Cancer Center1998-09-01
Study of the Effects of Temperature on Metabolism in Human Muscle (NCT00001753)National Heart, Lung, and Blood Institute (NHLBI)1998-09-01
Safety and Effectiveness of Immunotherapy With Autologous HIV-Specific CD8 Cells in HIV Infected Adults (NCT00110578)National Institute of Allergy and Infectious Diseases (NIAID)1998-09-01
Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects (NCT02218684)Boehringer Ingelheim1998-09-01
Raltitrexed in Treating Children With Refractory Acute Leukemia (NCT00003528)National Cancer Institute (NCI)1998-09-01
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis (NCT00004494)Stony Brook University1998-09-01
Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome (NCT00003415)University of Arizona1998-09-01
Chemotherapy in Treating Patients With Breast Cancer (NCT00012129)NYU Langone Health1998-09-01
An Open Protocol for the Compassionate Use of Thalidomide (NCT00081757)University of Arkansas1998-09-01
Gene Therapy in Treating Patients With Ovarian Cancer (NCT00003588)National Cancer Institute (NCI)1998-09-01
Irinotecan in Treating Children With Refractory or Progressive Solid Tumors (NCT00016861)Texas Children's Cancer Center1998-09-01
Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer (NCT00004048)Garden State Cancer Center at the Center for Molecular Medicine and Immunology1998-09-01
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer (NCT00003439)National Cancer Institute (NCI)1998-08-01
Geldanamycin Analogue in Treating Patients With Advanced Cancer (NCT00003969)Cancer Research UK1998-08-01
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas (NCT00019513)National Institutes of Health Clinical Center (CC)1998-08-01
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer (NCT00003633)Herbert Irving Comprehensive Cancer Center1998-08-01
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity (NCT00003548)NYU Langone Health1998-08-01
Arsenic Trioxide in Treating Patients With Advanced Solid Tumors (NCT00003630)Memorial Sloan Kettering Cancer Center1998-08-01
Drug Interactions Among Anti-HIV Agents (NCT00001766)National Institute of Allergy and Infectious Diseases (NIAID)1998-08-01
Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma (NCT02203864)Boehringer Ingelheim1998-08-01
Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer (NCT00652691)Mayo Clinic1998-08-01
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer (NCT00003378)Gynecologic Oncology Group1998-08-01
Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors (NCT00003710)The University of Texas Health Science Center at San Antonio1998-08-01
Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00004184)University of Alabama at Birmingham1998-08-01
Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma (NCT00186862)St. Jude Children's Research Hospital1998-08-01
Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors (NCT00003288)National Cancer Institute (NCI)1998-08-01
SR-45023A in Treating Patients With Advanced Solid Tumors (NCT00003822)Genzyme, a Sanofi Company1998-08-01
Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer (NCT00003344)Medical University of South Carolina1998-08-01
Irinotecan in Treating Patients With Advanced Solid Tumors (NCT00004051)Memorial Sloan Kettering Cancer Center1998-08-01
Achilles Tendon Lengthening in Patients With Diabetes to Prevent Foot Ulcers (NCT00006426)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1998-08-01
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer (NCT00003451)National Cancer Institute (NCI)1998-08-01
Irofulven in Treating Children With Recurrent or Refractory Solid Tumors (NCT00003370)National Cancer Institute (NCI)1998-08-01
Allogeneic Tumor Cell Vaccination in Patients With Solid Tumors (NCT00148993)Hadassah Medical Organization1998-07-01
T-Cell Vaccination in Multiple Sclerosis (MS) (NCT00220428)Sheba Medical Center1998-07-01
Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas (NCT00003410)Jonsson Comprehensive Cancer Center1998-07-01
SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma (NCT00003720)Pfizer1998-07-01
Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers (NCT02264067)Boehringer Ingelheim1998-07-01
Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas (NCT00003463)Duke University1998-07-01
Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults (NCT00474279)University of Virginia1998-07-01
Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection (NCT02199886)Boehringer Ingelheim1998-07-01
Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects (NCT02266485)Boehringer Ingelheim1998-07-01
Phase I Study of Adenoviral Vector Mediated Gene Transfer for Ornithine Transcarbamylase in Adults With Partial Ornithine Transcarbamylase Deficiency (NCT00004498)University of Pennsylvania1998-07-01
Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00003409)Jonsson Comprehensive Cancer Center1998-07-01
Chemotherapy in Treating Patients With Solid Tumors (NCT00003698)University of Glasgow1998-07-01
Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00003555)State University of New York - Upstate Medical University1998-07-01
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions (NCT00652730)Par Pharmaceutical, Inc.1998-07-01
Irinotecan in Treating Patients With Recurrent Malignant Glioma (NCT00003301)New Approaches to Brain Tumor Therapy Consortium1998-07-01
Interleukin-12 in Treating Patients With Advanced Cancer (NCT00003330)National Cancer Institute (NCI)1998-07-01
Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00003708)The University of Texas Health Science Center at San Antonio1998-07-01
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00005792)H. Lee Moffitt Cancer Center and Research Institute1998-06-02
UCN-01 in Treating Patients With Advanced Cancer (NCT00003289)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1998-06-01
Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males (NCT02265302)Boehringer Ingelheim1998-06-01
Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT00009802)University of Pittsburgh1998-06-01
Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer (NCT00178256)University of Rochester1998-06-01
Vector Delivery of the IL-12 Gene in Men With Prostate Cancer (NCT00406939)Baylor College of Medicine1998-06-01
Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers (NCT02199873)Boehringer Ingelheim1998-06-01
Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer (NCT00003434)Duke University1998-06-01
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions (NCT00653419)Par Pharmaceutical, Inc.1998-06-01
Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00003391)Weill Medical College of Cornell University1998-06-01
Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02198352)Boehringer Ingelheim1998-06-01
Immunotherapy in Treating Patients With Metastatic Breast Cancer (NCT00003432)Duke University1998-06-01
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies (NCT00001748)National Heart, Lung, and Blood Institute (NHLBI)1998-06-01
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer (NCT00003819)Memorial Sloan Kettering Cancer Center1998-06-01
Flt3L in Treating Patients With Metastatic Colorectal Cancer (NCT00003431)Duke University1998-06-01
Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects (NCT02266498)Boehringer Ingelheim1998-06-01
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis (NCT00003368)National Cancer Institute (NCI)1998-06-01
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis (NCT01188733)Mayo Clinic1998-06-01
Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia (NCT00317876)Fred Hutchinson Cancer Center1998-06-01
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma (NCT00003541)Memorial Sloan Kettering Cancer Center1998-06-01
Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00003543)Memorial Sloan Kettering Cancer Center1998-06-01
Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy (NCT00019357)National Cancer Institute (NCI)1998-06-01
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation (NCT00003412)Beth Israel Deaconess Medical Center1998-06-01
Immunotherapy in Treating Patients With Resected Liver Metastases From Colon Cancer (NCT00003433)Duke Cancer Institute1998-06-01
Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma (NCT00572013)University of Nebraska1998-05-12
LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors (NCT00019435)National Cancer Institute (NCI)1998-05-01
Bone Development in Adolescent Girls: Effects of Calcium and Exercise (NCT00063011)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1998-05-01
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia (NCT00003174)Barbara Ann Karmanos Cancer Institute1998-05-01
Interferon Alfa in Treating Patients With Advanced Kidney Cancer (NCT00003542)Memorial Sloan Kettering Cancer Center1998-05-01
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma (NCT00614913)Loma Linda University1998-05-01
Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease (NCT00806728)MedImmune LLC1998-05-01
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer (NCT00003382)Gynecologic Oncology Group1998-05-01
Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer (NCT00008099)University of Pittsburgh1998-05-01
Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects (NCT02264197)Boehringer Ingelheim1998-05-01
Melphalan With BBBD in Treating Patients With Brain Malignancies (NCT00253721)OHSU Knight Cancer Institute1998-05-01
Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer (NCT00003435)Duke University1998-05-01
Fenretinide in Treating Patients With Solid Tumors (NCT00003250)Barbara Ann Karmanos Cancer Institute1998-05-01
Bryostatin and Vincristine in B-Cell Malignancies (NCT00003166)National Cancer Institute (NCI)1998-05-01
New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis (NCT00001736)National Eye Institute (NEI)1998-05-01
Combination Chemotherapy In Treating Patients With Advanced Cancer (NCT00003925)Barbara Ann Karmanos Cancer Institute1998-05-01
3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors (NCT00004213)Vion Pharmaceuticals1998-05-01
Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain (NCT00003348)Duke University1998-05-01
Cyclosporin Implant to Treat Uveitis (NCT00001737)National Eye Institute (NEI)1998-05-01
Gene Therapy in Treating Patients With Advanced Bladder Cancer (NCT00003167)National Cancer Institute (NCI)1998-05-01
Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers (NCT00003249)National Cancer Institute (NCI)1998-05-01
Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer (NCT00004085)Garden State Cancer Center at the Center for Molecular Medicine and Immunology1998-05-01
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer (NCT00003380)Gynecologic Oncology Group1998-05-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.